MIRApeel Transdermal Delivery System
MIRApeelâ„¢ will let practitioners deliver popular services with better control and better outcomes than traditional options, in less time and with faster monetization and return on their investment
SAN DIEGO February 15, 2018
eMIRAmed USA (http://www.emiramed.com/) announced today it will demonstrate the distinctive design and performance benefits of the MIRApeelâ„¢ Transdermal Delivery System at the 2018 Annual Meeting of the American Academy of Dermatology, held February 16-20 in San Diego, California (https://www.aad.org/meetings/annual-meeting).
Developed by aesthetics equipment manufacturer MIRAmedtech UG, MIRApeelâ„¢ provides dermatologists with an integrated cosmetic enhancement system that delivers serums through state-of-the-art micro needling and desquamating attachments.
â€œConsumer demand for rejuvenation services that improve skin texture and tone and diminish imperfections continues to spike,â€� noted Serge Castro, eMIRAmed USA CEO. â€œMIRApeelâ„¢ will let practitioners deliver these popular services with better control and better outcomes than traditional options, in less time and with faster monetization and return on their investment.”
The MIRApeelâ„¢ System distributed by eMIRAmed USA consists of MIRArollerâ„¢, a non-invasive micro needling attachment; MIRAbrasorâ„¢, a 3D desquamating attachment with Fractional Transbrasionâ„¢ technology; and MIRAjolieâ„¢, a range of highly-efficacious serums that moisturize, exfoliate, detox, and nourish skin.
The MIRArollerâ„¢ tip features tightly-positioned microprotrusions which lightly abrade the skin surface. It offers a high degree of control. Because MIRArollerâ„¢ operation is vacuum-assisted, it enables more serum to be suffused with each pass. The novel MIRAbrasorâ„¢ attachment features a malleable top that permits its attached head to glide over skin with optimum dexterity, producing abraded skin that appears silky smooth. Both MIRApeelâ„¢ attachments are designed to support face or neck and body procedures.
â€œInnovation has been a hallmark of the MIRAmedtech brand for forty years,â€� said Castro, â€œand that trait is fully present in the new MIRApeelâ„¢ System.â€�
Collaboration with Bel Mondo Beauty at AAD 2018
Demonstrations of the MIRApeelâ„¢ System at eMIRAmedâ€™s booth (1359) will include treatment masks developed by Bel Mondo Beauty (http://www.belmondobeauty.com). Bel Mondo specializes in mask fabrics made exclusively from bio cellulose, an advanced fabric with therapeutic properties and a trusted safety profile.
Bel Mondoâ€™s Calming Mask and Hydrating Mask are popular add-ons following a variety of resurfacing services offered by medical aestheticians and dermatologists; bio cellulose fabrics excel at replenishing moisture, alleviating redness, and accelerating healing.
â€œWe are honored to collaborate with an innovative manufacturer like MIRAmedtech and have the complementary value of our premium mask line showcased at AAD,â€� stated Bel Mondo President Lou Martelli.
About eMIRAmed USA
eMIRAmed USA, LLC is importer and exclusive distributor of the full range of the MIRA products for the US, based in Irvine, CA. Visit http://www.emiramed.com/ for more information and follow us on Facebook, Instagram, and LinkedIN.
MIRA is a German brand of MIRAmedtech UG, which manufactures, markets and sells the MIRA products directly or through distribution partners worldwide.
About Bel Mondo Beauty
Bel Mondo Beauty develops and markets premium-grade treatment masks, made exclusively from bio cellulose fabrics. Our distinctive line of products is sold through spas and medical spas and select retail channels. Visit http://www.belmondobeauty.com for more information, and follow us on Facebook and Twitter.
Latest posts by Sarah Thompson (see all)
- The J.M. Smucker Company Previews New Premium Coffee Brand - February 21, 2018
- GreenTree Inn Hotels Announce Partnership with San Francisco Bay Coffee Co., Bringing Eco-Friendly, Compostable Coffee Pods - February 21, 2018
- Compugen Reports Fourth Quarter and Full Year 2017 Results - February 21, 2018